SUBSCRIBE
SUBSCRIBE

Nick Paul Taylor

Nick is a freelance writer who has been reporting on the global life sciences industry since 2008. With a BSc in biology, Nick writes about the science and business of biopharma and medtech for numerous healthcare publications. He can be reached at nick.paul.taylor@gmail.com or on LinkedIn.

USA, EU and Greenland on the map of North Atlantic Ocean in soft grunge and vintage style, like old paper with watercolor painting.
Manufacturing
Lilly and Boehringer roll back billions in German investments over health budget cuts
With Germany moving to curb healthcare spending, Eli Lilly and Boehringer Ingelheim have rethought plans to invest in facilities, including a manufacturing plant for GLP-1 drugs.
June 4, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Medication Warning: Yellow Caution Sign with Scattered Capsules
Manufacturing
FDA hits Medline with warning letter over long-running contamination problem
FDA inspectors found that Medline, which raised billions of dollars last year, failed to prevent repeat bacterial contamination of finished drug products.
June 3, 2026
 · 
2 min read
 · 
Nick Paul Taylor
concept of rising drug prices
Manufacturing
Pharma manufacturing projected to create 19,000 jobs through 2034
The forecast makes pharma one of the fastest-growing manufacturing industries in the U.S.
June 3, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Illustration of two arrows merging into one
Manufacturing
CordenPharma inks AmbioPharm buyout to continue peptide production expansion
Swiss service provider CordenPharma is acquiring AmbioPharm, gaining facilities such as a plant in South Carolina to provide a fully U.S.-based supply.
June 1, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Vector Illustration Healthy Lungs Gradient Colorful Style.
Lung cancer
ASCO: Kelun-Merck ADC shines with differentiated overall survival in first-line lung cancer
Interim overall survival data on a TROP2 ADC from Merck and Chinese partner Kelun-Biotech provide support for the pharma’s big bet on its potential to help navigate Keytruda’s impending loss of exclusivity.
June 1, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Laptop with envelope and document with exclamation mark on screen. Receive notification, alert message, warning, get e-mail, email, spam concepts. Flat design vector illustration
Manufacturing
Cracked gaskets and rust-like residues trigger FDA warning letter to Alchymars
FDA inspectors found Alchymars failed to adequately maintain equipment used to make active pharmaceutical ingredients for the U.S. market. Over-the-counter drugmakers GC America and Sato Pharmaceutical also received warning letters.
May 29, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Active construction site with cranes, workers, builders and skyscrapers under development. Process of building. Vector illustration. Line art style. Isometric view of a monolithic frame building.
Manufacturing
Niowave, fresh from Novartis deal, starts building $75M radioisotope plant
Having secured deals with AstraZeneca and Novartis, Niowave is constructing a second facility to meet rising demand for actinium-225, which can be used to develop next-generation radiopharmaceuticals.
May 26, 2026
 · 
2 min read
 · 
Nick Paul Taylor
High Quality background with Two Flags of South Korea and USA
Manufacturing
Gilead inks $140M API supply deal, tightening ties to Korean manufacturer
The agreement is the largest in a series of deals that Gilead Sciences has penned with Korea’s Yuhan.
May 22, 2026
 · 
1 min read
 · 
Nick Paul Taylor
too many different pill of various blisters with different pills Medicines storage at home concept Medication storing. A pile of medicine in blister packs. Pharmaceutical blister packs.
Manufacturing
Roche licensing pact clears generic drugmakers to manufacture antiviral flu drug
By partnering with a UN-backed body, Roche has enabled companies to make the medicine for supply in 129 countries.
May 21, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Email envelope with warning sign on white background
Manufacturing
FDA sends warning letter after Chinese supplier breaks GLP-1 import restrictions
While the manufacturer is on the list of authorized GLP-1 importers, FDA inspectors found the company relabeled APIs from another site in a potential attempt to “circumvent safeguards.”
May 20, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Digital isometric background red warning alert icon and decreasing stock market graph, economic crisis, financial risk, and market crash.
Vaccines
Moderna’s stock rides hantavirus fears as spotlight returns to infectious disease platform
While the pathogen appears unlikely to trigger a pandemic, analysts see potential for Moderna to build goodwill amid a period of political pressure on vaccine manufacturers.
May 20, 2026
 · 
4 min read
 · 
Nick Paul Taylor
Businessman finds himself difficult to make decision because of too many directions or choices to choose. Cute character vector illustration, outline, thin line art, hand drawn sketch, black and white ink style.
Antibody-drug conjugate (ADC)
Daiichi emerges from bruising 2 years with vision for cracking cancer’s big leagues
Clinical trial setbacks have limited the near-term opportunities for some of Daiichi Sankyo’s ADCs but the drug developer is betting near-term readouts will catapult it into the top tier of oncology companies in the coming years.
May 20, 2026
 · 
4 min read
 · 
Nick Paul Taylor
Vector illustration. Product recall.
Manufacturing
Sun Pharma recalls cancer drug after finding glass particles in some vials
A batch of a chemotherapy product made at a Sun facility with a history of quality and compliance issues is being withdrawn from the U.S. market.
May 15, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Smart industry and digital manufacturing concept with glowing polygonal factory connected to circuit board on dark blue background. Futuristic low poly style, abstract vector illustration.
Manufacturing
Bora inks $122.5M takeover of MacroGenics facility to further US expansion
MacroGenics is selling the manufacturing plant to Bora, a Taiwan-based CDMO, to raise cash to support the progress of its drug development pipeline.
May 13, 2026
 · 
2 min read
 · 
Nick Paul Taylor
US (UNITED STATES) VS EU (EUROPEAN UNION) - Trade war and politics conflicts concept - Concept with flags painted on cracked wall
Mergers & acquisitions
Mid-sized European drugmakers are snapping up US biotechs. Will the surge continue?
European pharma companies splashed billions of dollars into the U.S. biopharma sector in a matter of days, but there are differing views on whether the activity represents the rise of a new buyer class or a quirk of timing.
May 13, 2026
 · 
4 min read
 · 
Nick Paul Taylor
Load More